Status:
COMPLETED
CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Sleep Apnea Syndromes
Eligibility:
All Genders
18+ years
Brief Summary
The hypothesis of this work is that the COVID 19 pandemic and the associated lockdowns are likely to modify the adherence to positive airway pressure (PAP) treatments among patients with sleep apnea. ...
Detailed Description
The primary objective of this study is to compare PAP adherence during lockdowns in 2020 with the corresponding weeks during 2019.
Eligibility Criteria
Inclusion
- patient treated/monitored by the Adene group
- treated for sleep apnea syndrome (i.e., an initial apnoea hypopnea index (iAHI) ≥ 30/h or iAHI ≥ 15/h (and more than 10/h respiratory-effort-related arousal or cardio-metabolic/respiratory comorbidities) associated with symptoms from among sleepiness, tiredness, snoring, headaches, hypertension, reduced vigilance, libido disorders, nocturia, choking or suffocation during sleep, daytime tiredness)
- Positive airway pressure (PAP)-treated for at least 4 months before January 1, 2019
- continuous PAP during 2019
- continuous PAP during 2020
- acceptance of PAP telemonitoring with consent given for data collection and data anonymization
Exclusion
- less than 360 daily PAP tele-monitored data per year for 2019
- less than 360 daily PAP tele-monitored data per year for 2020
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 15 2021
Estimated Enrollment :
8477 Patients enrolled
Trial Details
Trial ID
NCT04775966
Start Date
January 15 2021
End Date
February 15 2021
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Adene Group
Montpellier, France